• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中文常染色体显性遗传包涵体肌病伴脑铁沉积 8 型(GLT8D1)相关运动神经元病基因突变筛查及负担分析。

Mutation screening and burden analysis of GLT8D1 in Chinese patients with amyotrophic lateral sclerosis.

机构信息

Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare disease Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Neurobiol Aging. 2021 May;101:298.e17-298.e21. doi: 10.1016/j.neurobiolaging.2020.10.017. Epub 2020 Oct 22.

DOI:10.1016/j.neurobiolaging.2020.10.017
PMID:33581933
Abstract

The glycosyltransferase 8 domain containing 1 (GLT8D1) gene was identified to be an amyotrophic lateral sclerosis (ALS)-causative gene via pedigree cosegregation and burden analysis. In the present study, 977 Chinese sporadic ALS (sALS) cases and 47 Chinese familial ALS (fALS) cases underwent whole-exome sequencing. Rare variants with minor allele frequency <0.1% in GLT8D1 were analyzed. One likely pathogenic variant in the exon 4 was identified in a fALS case and validated within the family. Moreover, 3 rare variants of uncertain significance in 4 patients with sALS and 1 rare variant of uncertain significance in 1 patient with fALS were also identified. Furthermore, by using the East Asian controls from the gnomAD database, there was no significant enrichment of rare variants of GLT8D1 at the whole-gene level or the exon 4-specific level in Chinese patients with sALS. In conclusion, cosegregation findings further support the pathogenic role of GLT8D1 in fALS. However, no pathogenic mutation and no enrichment of rare variants were found in patients with sALS, which implies that GLT8D1 may not play a role in Chinese patients with sALS.

摘要

通过家系共分离和负担分析,发现糖基转移酶 8 结构域包含 1 号(GLT8D1)基因是肌萎缩侧索硬化症(ALS)的致病基因。本研究对 977 例中国散发性 ALS(sALS)病例和 47 例中国家族性 ALS(fALS)病例进行了全外显子组测序。分析了 GLT8D1 中次要等位基因频率<0.1%的罕见变异。在一个 fALS 病例中发现了外显子 4 中的一个可能致病变异,并在家族内进行了验证。此外,在 4 例 sALS 患者中发现了 3 个意义未明的罕见变异,在 1 例 fALS 患者中发现了 1 个意义未明的罕见变异。此外,通过使用 gnomAD 数据库中的东亚对照,在 sALS 中国患者中,GLT8D1 的全基因水平或外显子 4 特异性水平均未发现罕见变异的显著富集。总之,共分离发现进一步支持 GLT8D1 在 fALS 中的致病作用。然而,在 sALS 患者中未发现致病性突变和罕见变异的富集,这表明 GLT8D1 可能在 sALS 中国患者中不起作用。

相似文献

1
Mutation screening and burden analysis of GLT8D1 in Chinese patients with amyotrophic lateral sclerosis.中文常染色体显性遗传包涵体肌病伴脑铁沉积 8 型(GLT8D1)相关运动神经元病基因突变筛查及负担分析。
Neurobiol Aging. 2021 May;101:298.e17-298.e21. doi: 10.1016/j.neurobiolaging.2020.10.017. Epub 2020 Oct 22.
2
GLT8D1 may not be significant in Chinese sporadic amyotrophic lateral sclerosis patients.GLT8D1 在中国人散发性肌萎缩侧索硬化症患者中可能不重要。
Neurobiol Aging. 2021 Jun;102:224.e1-224.e3. doi: 10.1016/j.neurobiolaging.2021.01.028. Epub 2021 Feb 7.
3
Mutation analysis of GLT8D1 and ARPP21 genes in amyotrophic lateral sclerosis patients from mainland China.中国内地肌萎缩侧索硬化症患者 GLT8D1 和 ARPP21 基因突变分析。
Neurobiol Aging. 2020 Jan;85:156.e1-156.e4. doi: 10.1016/j.neurobiolaging.2019.09.013. Epub 2019 Sep 25.
4
Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis.GLT8D1 和 ARPP21 在澳大利亚家族性和散发性肌萎缩侧索硬化症中的遗传分析。
Neurobiol Aging. 2021 May;101:297.e9-297.e11. doi: 10.1016/j.neurobiolaging.2021.01.005. Epub 2021 Jan 16.
5
Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis.GLT8D1 糖基转移酶结构域的突变与家族性肌萎缩侧索硬化症有关。
Cell Rep. 2019 Feb 26;26(9):2298-2306.e5. doi: 10.1016/j.celrep.2019.02.006.
6
Validation of the pathogenic role of rare DNAJC7 variants in Chinese patients with amyotrophic lateral sclerosis.验证罕见 DNAJC7 变异在中国肌萎缩侧索硬化症患者中的致病性作用。
Neurobiol Aging. 2021 Oct;106:314.e1-314.e6. doi: 10.1016/j.neurobiolaging.2021.04.026. Epub 2021 May 5.
7
Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis.日本肌萎缩侧索硬化症病例系列中 KIF5A 的剪接位点突变。
Neurogenetics. 2021 Mar;22(1):11-17. doi: 10.1007/s10048-020-00626-1. Epub 2020 Aug 19.
8
Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.中国肌萎缩侧索硬化症患者CHCHD10基因的突变筛查
Mol Neurobiol. 2017 Jul;54(5):3189-3194. doi: 10.1007/s12035-016-9888-0. Epub 2016 Apr 7.
9
Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS.导致肌萎缩侧索硬化症 (ALS) 的罕见变异基因的负担会加速 ALS 的发病年龄。
J Neurol Neurosurg Psychiatry. 2019 May;90(5):537-542. doi: 10.1136/jnnp-2018-318568. Epub 2018 Oct 24.
10
Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.肌萎缩侧索硬化症的遗传流行病学:系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):540-549. doi: 10.1136/jnnp-2016-315018. Epub 2017 Jan 5.

引用本文的文献

1
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.肌萎缩侧索硬化症:疾病病理生理学、生物标志物与治疗方法的见解及新前景
Pharmaceuticals (Basel). 2024 Oct 18;17(10):1391. doi: 10.3390/ph17101391.
2
Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis.肌萎缩侧索硬化症分子遗传发病机制的当前见解
Front Neurosci. 2023 Aug 10;17:1189470. doi: 10.3389/fnins.2023.1189470. eCollection 2023.
3
Genetic and Functional Analysis of Glycosyltransferase 8 Domain-Containing Protein 1 in Taiwanese Patients With Amyotrophic Lateral Sclerosis.
台湾肌萎缩侧索硬化症患者中含糖基转移酶8结构域蛋白1的基因与功能分析
Neurol Genet. 2021 Nov 3;7(6):e627. doi: 10.1212/NXG.0000000000000627. eCollection 2021 Dec.
4
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies.肌萎缩侧索硬化症:分子机制、生物标志物与治疗策略
Antioxidants (Basel). 2021 Jun 24;10(7):1012. doi: 10.3390/antiox10071012.